Sutro BioPharma Inc
Sutro BioPharma Inc., a pioneering biotechnology company headquartered in the United States, focuses on the development of innovative therapeutics for cancer and other serious diseases. Founded in 2003, Sutro has made significant strides in the biopharmaceutical industry, particularly in the areas of protein engineering and drug development. The company is renowned for its proprietary XpressCF™ platform, which enables the rapid and efficient production of complex proteins, setting it apart from competitors. Sutro's core offerings include antibody-drug conjugates and other biologics, designed to enhance therapeutic efficacy while minimising side effects. With a strong market position, Sutro BioPharma has achieved notable milestones, including strategic partnerships and advancements in clinical trials, solidifying its reputation as a leader in the biopharmaceutical landscape.
DitchCarbon Score
How does Sutro BioPharma Inc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sutro BioPharma Inc's score of 3 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sutro BioPharma Inc's reported carbon emissions
Sutro BioPharma Inc, headquartered in the US, currently does not have available data on its carbon emissions, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the absence of concrete emissions data, it is essential to note that many companies in the biopharmaceutical sector are increasingly focusing on sustainability and climate commitments. This trend often includes setting science-based targets for emissions reductions and engaging in initiatives aimed at minimising their carbon footprint. As the industry evolves, it is likely that Sutro BioPharma will align with these practices to enhance its environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sutro BioPharma Inc is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
